BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21902576)

  • 1. Genetic alterations in members of the Wnt pathway in acute leukemia.
    Erbilgin Y; Ng OH; Mavi N; Ozbek U; Sayitoglu M
    Leuk Lymphoma; 2012 Mar; 53(3):508-10. PubMed ID: 21902576
    [No Abstract]   [Full Text] [Related]  

  • 2. [Genetic Polymorphisms in Wnt Signaling Pathway and Acute Leukemia].
    Zhang LJ; Zhou J; Ye YX; Lu XJ; Jiang H; Mao ZG; Zeng SG; Ying BW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 May; 46(3):403-8. PubMed ID: 26121862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of BCORL1 in the leukemic transformation of chronic myeloproliferative neoplasms.
    Rotunno G; Guglielmelli P; Biamonte F; Rumi E; Cazzola M; Vannucchi AM
    Ann Hematol; 2014 Mar; 93(3):523-4. PubMed ID: 23793880
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinicopathological analysis of β-catenin and Axin-1 in solid pseudopapillary neoplasms of the pancreas.
    Huang SC; Ng KF; Yeh TS; Chang HC; Su CY; Chen TC
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S438-46. PubMed ID: 21769465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of MYH Tyr165Cys and Gly382Asp variants in childhood leukemias.
    Akyerli CB; Ozbek U; Aydin-Sayitoğlu M; Sirma S; Ozçelik T
    J Cancer Res Clin Oncol; 2003 Oct; 129(10):604-5. PubMed ID: 12920580
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preliminary study on polymorphism of GSTM1, CYP2E1 and NQO1 genes and risk factors of children leukemia].
    Wu YX; Gao YJ; Zhao JC; Jing XP; Xia ZL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):819. PubMed ID: 15555372
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mutation analysis of SHIP gene in acute leukemia].
    Luo JM; Liu ZL; Hao HL; Wang FX; Dong ZR; Ryuzo O
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):385-8. PubMed ID: 15355687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The overexpression of KIT proto-oncogene in acute leukemic cells is not necessarily caused by the gene mutation.
    Szatkowski D; Hellmann A
    Acta Haematol; 2015; 133(1):116-23. PubMed ID: 25247397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration in the Wnt/β-catenin signaling pathway in gastric neoplasias of fundic gland (chief cell predominant) type.
    Hidaka Y; Mitomi H; Saito T; Takahashi M; Lee SY; Matsumoto K; Yao T; Watanabe S
    Hum Pathol; 2013 Nov; 44(11):2438-48. PubMed ID: 24011952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and biological significance of CD34 expression in acute leukemia.
    Basso G; Lanza F; Orfao A; Moretti S; Castoldi G
    J Biol Regul Homeost Agents; 2001; 15(1):68-78. PubMed ID: 11388747
    [No Abstract]   [Full Text] [Related]  

  • 11. BRAF mutations in acute leukemias.
    Lee JW; Soung YH; Park WS; Kim SY; Nam SW; Min WS; Lee JY; Yoo NJ; Lee SH
    Leukemia; 2004 Jan; 18(1):170-2. PubMed ID: 14603338
    [No Abstract]   [Full Text] [Related]  

  • 12. A single amino acid change A91V in perforin: a novel, frequent predisposing factor to childhood acute lymphoblastic leukemia?
    Santoro A; Cannella S; Trizzino A; Lo Nigro L; Corsello G; Aricò M
    Haematologica; 2005 May; 90(5):697-8. PubMed ID: 15921391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism of glutathione S-transferase Omega gene: association with risk of childhood acute lymphoblastic leukemia.
    Pongstaporn W; Pakakasama S; Sanguansin S; Hongeng S; Petmitr S
    J Cancer Res Clin Oncol; 2009 May; 135(5):673-8. PubMed ID: 18941778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of Variations in CD22 Gene in Children with B-Precursor Acute Lymphoblastic Leukemia.
    Aslar Oner D; Akin DF; Sipahi K; Mumcuoglu M; Ezer U; Kürekci AE; Akar N
    Genet Test Mol Biomarkers; 2016 Sep; 20(9):552-5. PubMed ID: 27486888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of the APC, beta-catenin, and axin 1 genes and cytoplasmic accumulation of beta-catenin in oral squamous cell carcinoma.
    Iwai S; Katagiri W; Kong C; Amekawa S; Nakazawa M; Yura Y
    J Cancer Res Clin Oncol; 2005 Dec; 131(12):773-82. PubMed ID: 16163548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exon concatenation to increase the efficiency of mutation screening by DGGE.
    Agirre X; García-Delgado M; Calasanz MJ; Larráyoz MJ; Novo FJ; Vizmanos JL
    Biotechniques; 2002 May; 32(5):1064-5, 1068-70. PubMed ID: 12019779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromodeoxyuridine incorporation into DNA of human leukemia cells is not concentration dependent.
    Powell BL; Gregory BW; Kute TE; Morgan TM; Lyerly ES; Capizzi RL
    Cytometry; 1990; 11(3):438-41. PubMed ID: 2340778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Flt-3/ITD mutation in pediatric leukemia and its clinical significance].
    Wang J; Wang T; Li S; Lin L; Gang Y
    Ai Zheng; 2007 Jan; 26(1):58-63. PubMed ID: 17222369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of DOK2 tumor suppressor gene in acute leukemias.
    Kim MS; Chung NG; Yoo NJ; Lee SH
    Leuk Res; 2011 Jun; 35(6):e87-8. PubMed ID: 21329978
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia.
    Zhu YM; Foroni L; McQuaker IG; Papaioannou M; Haynes A; Russell HH
    Br J Cancer; 1999 Mar; 79(7-8):1151-7. PubMed ID: 10098750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.